Discriminative ability of conventional echocardiography and tissue Doppler imaging techniques for the detection of subclinical cardiotoxic effects of treatment with anthracyclines

Ultrasound in Medicine and Biology

Volumn 27, Issue 12, 2001, Pages 1605-1614

  Kapusta, Livia ^a   Thijssen, Johan M ^a   Groot Loonen, Jacqueline ^a   Van Druten, Johannes A M ^a   Daniëls, Otto ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Anthracyclines; Cardiotoxicity; Discriminative ability; Echocardiography; Multivariate statistics; Tissue Doppler imaging

Indexed keywords

DOPPLER EFFECT; ECHOCARDIOGRAPHY; PATIENT MONITORING;

CARDIOMYOPATHY;

MEDICAL IMAGING;

ANTHRACYCLINE; BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; METHOTREXATE; VINCRISTINE;

ADOLESCENT; ARTICLE; CANCER; CANCER SURVIVAL; CARDIOTOXICITY; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIASTOLE; DOPPLER ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY; FEMALE; FLOW RATE; FOLLOW UP; HEART LEFT VENTRICLE CONTRACTION; HEART MUSCLE INJURY; HUMAN; IMAGE QUALITY; INTERMETHOD COMPARISON; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE; PARAMETER; PERFORMANCE; PRIORITY JOURNAL; PROBABILITY; SCHOOL CHILD; SCORING SYSTEM;

ADOLESCENT; ANTIBIOTICS, ANTINEOPLASTIC; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; DISCRIMINANT ANALYSIS; ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HEART DISEASES; HUMANS; LOGISTIC MODELS; MALE; NEOPLASMS; RETROSPECTIVE STUDIES; ROC CURVE;

EID: 0035706975     PISSN: 03015629     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-5629(01)00470-7     Document Type: Article

References (48)

1. Effect of loading conditions on myocardial relaxation velocities determined by Doppler tissue imaging in heart transplant recipients
2. Quantitative assessment of regional systolic and diastolic myocardial velocities during transient ischemia and reperfusion
3. The pathology of anthracycline cardiotoxicity in children, adolescents, and adults
4. Anthracycline cardiomyopathy monitored by morphologic changes
5. Clinical spectrum of anthracycline antibiotic cardiotoxicity
6. Left ventricular diastolic function after anthracycline chemotherapy in childhood: Relation with systolic function, symptoms, and pathophysiology
7. Early identification of anthracycline cardiomyopathy: Possibilities and implications
8. Assessment of diastolic function by tissue Doppler echocardiography: Comparison with standard transmitral and pulmonary venous flow
9. Myocardial wall velocity assessment by pulsed Doppler tissue imaging: Characteristic findings in normal subjects
10. Differentiation of constrictive pericarditis from restrictive cardiomyopathy: Assessment of left ventricular diastolic velocities in longitudinal axis by Doppler tissue imaging
11. New Doppler echocardiographic applications for the study of diastolic function
12. Regional diastolic function in ischaemic heart disease using pulsed wave Doppler tissue imaging
13. Initial congestive heart failure, six to ten years after doxorubicin chemotherapy for childhood cancer
14. Long term doxorubicin cardiotoxicity in childhood: Non-invasive evaluation of the contractile state and diastolic filling
15. Doppler tissue imaging in congestive heart failure patients due to diastolic or systolic dysfunction: A comparison with Doppler echocardiography and the atrio-ventricular plane displacement technique
16. Assessment of myocardial velocities in healthy children using tissue Doppler imaging
17. Tissue Doppler imaging in detection of myocardial dysfunction in survivors of childhood cancer treated with anthracyclines
18. Clinical cardiotoxicity following anthracycline treatment for childhood cancer: The Pediatric Oncology Group experience
19. Tissue Doppler imaging discloses topographic localization of arrhythmias
20. The use of echocardiography and Holter monitoring in the assessment of anthracycline-treated patients
21. Cardiovascular abnormalities in long-term survivors of childhood malignancy
22. Ventricular tachycardia and sudden unexplained death in late survivors of childhood malignancy treated with doxorubicin
23. Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood
24. Left ventricular structure and function eleven years after doxorubicin treatment for childhood leukemia: Is this a restrictive cardiomyopathic process?
25. Female sex and drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer
26. Monitoring for anthracycline cardiotoxicity
27. New method for evaluating left ventricular wall motion by color-coded tissue Doppler imaging: In vitro and in vivo studies
28. Outcome of clinical congestive heart failure induced by anthracycline chemotherapy
29. Application of tissue Doppler imaging technique in evaluating early ventricular contraction associated with accessory atrioventricular pathways in Wolff-Parkinson-White syndrome
30. Late cardiotoxicity following anthracycline therapy for childhood cancer
31. Relationship between cumulative anthracycline dose and late cardiotoxicity in childhood acute lymphoblastic leukemia
32. Clinical application of pulsed Doppler tissue imaging for assessing abnormal left ventricular relaxation
33. Differences in myocardial velocity gradient measured throughout the cardiac cycle in patients with hypertrophic cardiomyopathy, athletes and patients with left ventricular hypertrophy due to hypertension
34. Anthracycline cardiomyopathy and impaired myocardial function in children: Outcome with angiotensin-converting enzyme inhibitor and digoxin therapy
35. Late cardiotoxicity after treatment for a malignant bone tumor
36. Noninvasive detection of allograft rejection in heart transplant recipients by use of Doppler tissue imaging
37. Tissue Doppler imaging and the quantification of myocardial function
38. Quantitative assessment of myocardial tissue velocities in normal children with Doppler tissue imaging
39. Assessment of mitral annulus velocity by Doppler tissue imaging in the evaluation of left ventricular diastolic function
40. Cardiac function in Wilms' tumor survivors
41. Cardiac toxicity 4 to 20 years after completing anthracycline therapy
42. Guidelines for cardiac monitoring of children during and after anthracycline therapy: Report of the Cardiology Committee of the Childrens Cancer Study Group
43. Cardiac failure and dysrhythmias 6-19 years after anthracycline therapy: A series of 15 patients
44. Echocardiographic evaluation of cardiac function in paediatric oncology patients treated with or without anthracycline
45. Myocardial velocity gradient as a new indicator of regional left ventricular contraction: Detection by a two-dimensional tissue Doppler imaging technique
46. Usefulness of myocardial velocity gradient derived from two-dimensional tissue Doppler imaging as an indicator of regional myocardial contraction independent of translational motion assessed in atrial septal defect
47. Myocardial Doppler velocity imaging-a quantitative technique for interpretation of dobutamine echocardiography